CHFR and cancer: In 2000, Scolnick and Halazonetis uncovered a Chfr-dependent pathway in human cell lines that delays mitotic transition from prophase to metaphase under mitotic stress and found that Chfr is mutated or not expressed in four cancer cell lines [246].